NASDAQ:ICLR - Icon Stock Price, Price Target & More

Icon trades on the NASDAQ under the ticker symbol "ICLR."

Icon Plc (NASDAQ:ICLR) announced its earnings results on Thursday, May, 3rd. The medical research company reported $1.42 earnings per share for the quarter, topping analysts' consensus estimates of $1.41 by $0.01. The medical research company had revenue of $620.13 million for the quarter, compared to the consensus estimate of $562.61 million. Icon had a return on equity of 26.56% and a net margin of 14.80%. The company's revenue was up 43.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.29 EPS. View Icon's Earnings History.

Icon is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Icon.

Icon updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided EPS guidance of $5.91-6.11 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.99. The company issued revenue guidance of $2.52-2.64 billion, compared to the consensus revenue estimate of $2.25 billion.

10 equities research analysts have issued 12 month price objectives for Icon's shares. Their forecasts range from $114.00 to $152.00. On average, they anticipate Icon's share price to reach $129.40 in the next twelve months. View Analyst Ratings for Icon.

Some companies that are related to Icon include IQVIA (IQV), Incyte (INCY), EXACT Sciences (EXAS), PRA Health Sciences (PRAH), Exelixis (EXEL), Charles River Laboratories Intl. (CRL), Syneos Health (SYNH), BTG (BTGGF), Intrexon (XON), Medpace (MEDP), National Research (NRCIB), Sorrento Therapeutics (SRNE), National Research (NRCIA), Eloxx Pharmaceuticals (ELOX) and Viralytics (VRACY).

Media stories about ICLR stock have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Icon earned a daily sentiment score of 0.13 on Accern's scale. They also gave news articles about the medical research company an impact score of 46.85 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Icon's stock is owned by a number of of institutional and retail investors. Top institutional investors include WCM Investment Management CA (8.25%), Earnest Partners LLC (4.01%), Wasatch Advisors Inc. (3.07%), Boston Partners (3.01%), Wells Fargo & Company MN (1.93%) and Principal Financial Group Inc. (1.75%). View Institutional Ownership Trends for Icon.

ICLR stock was sold by a variety of institutional investors in the last quarter, including Westfield Capital Management Co. LP, Earnest Partners LLC, Envestnet Asset Management Inc., Wasatch Advisors Inc., Victory Capital Management Inc., Fiera Capital Corp, Wells Fargo & Company MN and Loomis Sayles & Co. L P. View Insider Buying and Selling for Icon.

ICLR stock was bought by a variety of institutional investors in the last quarter, including Boston Partners, WCM Investment Management CA, Principal Financial Group Inc., Principal Financial Group Inc., Lord Abbett & CO. LLC, Massachusetts Financial Services Co. MA, American Century Companies Inc. and Baird Financial Group Inc.. View Insider Buying and Selling for Icon.

Shares of ICLR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ICLR stock can currently be purchased for approximately $134.77.

Icon has a market capitalization of $7.33 billion and generates $1.76 billion in revenue each year. The medical research company earns $281.48 million in net income (profit) each year or $5.39 on an earnings per share basis. Icon employs 13,250 workers across the globe.

Icon's mailing address is SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN, DUBLIN L2, 00000. The medical research company can be reached via phone at 353-1291-2000.